We demonstrate a versatile phase-change sub-micron contrast agent providing three modes of contrast enhancement: 1) photoacoustic imaging contrast, 2) ultrasound contrast with optical activation, and 3) ultrasound contrast with acoustic activation. This agent, which we name 'Cy-droplet', has the following novel features. It comprises a highly volatile perfluorocarbon for easy versatile activation, and a near-infrared optically absorbing dye chosen to absorb light at a wavelength with good tissue penetration. It is manufactured via a 'microbubble condensation' method. The phase-transition of Cy-droplets can be optically triggered by pulsed-laser illumination, inducing photoacoustic signal and forming stable gas bubbles that are visible with ...
Laser-activated perfluorocarbon nanodroplets (PFCnDs) are emerging phase-change contrast agents that...
Currently available microbubbles used for ultrasound imaging and therapeutics are limited to intrava...
The increasing personalization of medical treatment demands refined imaging and increased monitorin...
We demonstrate a versatile phase-change sub-micron contrast agent providing three modes of contrast ...
We demonstrate a versatile phase-change sub-micron contrast agent providing three modes of contrast ...
Ultrasound imaging with microbubbles offers substantial benefits and extended diagnostic application...
textMedical ultrasound imaging is ubiquitous in clinics due to its safety, low cost, portability, an...
Phase-change contrast agents (PCCAs) for ultrasound-based applications have resulted in novel ways o...
Phase-change contrast agents (PCCAs) for ultrasound-based applications have resulted in novel ways o...
Recent efforts in the area of acoustic droplet vaporization with the objective of designing extravas...
Recent efforts in the area of acoustic droplet vaporization with the objective of designing extravas...
Continued advances in the field of ultrasound and ultrasound contrast agents have created new approa...
Continued advances in the field of ultrasound and ultrasound contrast agents have created new approa...
Currently available microbubbles used for ultrasound imaging and therapeutics are limited to intrava...
In the past two decades, perfluorocarbon (PFC) droplets have been investigated for biomedical applic...
Laser-activated perfluorocarbon nanodroplets (PFCnDs) are emerging phase-change contrast agents that...
Currently available microbubbles used for ultrasound imaging and therapeutics are limited to intrava...
The increasing personalization of medical treatment demands refined imaging and increased monitorin...
We demonstrate a versatile phase-change sub-micron contrast agent providing three modes of contrast ...
We demonstrate a versatile phase-change sub-micron contrast agent providing three modes of contrast ...
Ultrasound imaging with microbubbles offers substantial benefits and extended diagnostic application...
textMedical ultrasound imaging is ubiquitous in clinics due to its safety, low cost, portability, an...
Phase-change contrast agents (PCCAs) for ultrasound-based applications have resulted in novel ways o...
Phase-change contrast agents (PCCAs) for ultrasound-based applications have resulted in novel ways o...
Recent efforts in the area of acoustic droplet vaporization with the objective of designing extravas...
Recent efforts in the area of acoustic droplet vaporization with the objective of designing extravas...
Continued advances in the field of ultrasound and ultrasound contrast agents have created new approa...
Continued advances in the field of ultrasound and ultrasound contrast agents have created new approa...
Currently available microbubbles used for ultrasound imaging and therapeutics are limited to intrava...
In the past two decades, perfluorocarbon (PFC) droplets have been investigated for biomedical applic...
Laser-activated perfluorocarbon nanodroplets (PFCnDs) are emerging phase-change contrast agents that...
Currently available microbubbles used for ultrasound imaging and therapeutics are limited to intrava...
The increasing personalization of medical treatment demands refined imaging and increased monitorin...